AI identifies TNIK protein and creates a drug that rewinds lung damage in pulmonary fibrosis, a breakthrough never seen before

AI DISCOVERS REVOLUTIONARY NEW WAY TO REVERSE LUNG DAMAGE

An AI system didn’t just design a new drug for pulmonary fibrosis; it first figured out which protein was causing the damage (TNIK), then designed a molecule to shut it down.

In a 12-week trial, patients on the highest dose gained almost 100 ml of lung capacity, something that’s never been achieved before with any other drug.

For a disease that usually only gets worse, that’s like hitting rewind on the damage.

Source: Nature Medicine

Uh-oh! It looks like you're using an ad blocker.

Our website relies on ads and the generous support of readers like you to keep delivering free, high-quality content. Right now, we are facing serious funding challenges and we need your help more than ever. Disable your ad blocker and this message will vanish. You can also sign up for a membership to enjoy an ad-free experience while supporting our work: https://citizenwatchreport.com/plans/subscriptions/ Your support helps us stay independent, continue our work, and keep content free for everyone. We truly appreciate your understanding and thank you for standing with us.